Posted By: Jennie Gunnerson
Sigenics is proud to be a partner in the groundbreaking NIH-sponsored clinical trial of the Intracortical Visual Prosthesis (ICVP) project.
Phil Troyk, President and CEO of Sigenics, is the principal investigator leading 8 institutions in this team effort to implant Sigenics-designed microchips into the brains of people with blindness, with the goal of restoring some of their vision.
The 8 institutions include:
- Sigenics, Inc.
- Illinois Institute of Technology
- Rush University Medical Center
- Johns Hopkins University
- University of Chicago
- University of Texas, Dallas
- Microprobes for Life Science, Inc.
- The Chicago Lighthouse for the Blind
For more details, and to listen to Phil describe the project in his own words, please click on the below link:
Intracortical Visual Prosthesis Trial to begin